Clinical predictors of Barrett's esophagus length

Gastrointestinal Endoscopy

Volumn 62, Issue 5, 2005, Pages 675-681

  Dickman, Ram ^b   Green, Colleen ^b   Chey, William D ^b   Jones, Michael P ^b   Eisen, Glenn M ^b   Ramirez, Francisco ^b   Briseno, Michael ^b   Garewal, Harinder S ^b   Fass, Ronnie ^a  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DYSPLASIA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HERNIA; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROTON PUMPS; RISK FACTORS;

EID: 27144441764     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2005.05.019     Document Type: Article

References (39)

1. A.J. Cameron, B.J. Ott, and W.S. Payne The incidence of adenocarcinoma in columnar-lines (Barrett's) esophagus N Engl J Med 313 1985 857 859
2. C. Winters, T.J. Spurling, S. Chobanian, D.J. Curtis, R.L. Esposito, and J. Hacker 3rd Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease Gastroenterology 921 1987 118 124
3. N.S. Mann, M.F. Tsai, and P.K. Nair Barrett's esophagus in patients with symptomatic reflux esophagitis Am J Gastroenterol 84 1989 1494 1496
4. A.J. Cameron, P.S. Kamath, and H.A. Carpenter Prevalence of Barrett's esophagus and intestinal metaplasia at the esophagogastric junction [abstract] Gastroenterology 112 1997 AB82
5. W.J. Blot, S.S. Devesa, R.W. Kneller, and J.F. Fraumeni Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
6. R.E. Sampliner The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus Am J Gastroenterol 97 2002 1888 1895
7. A.J. Cameron, and C.T. Lomboy Barrett's esophagus: age, prevalence, and extent of columnar epithelium Gastroenterology 103 1992 1241 1245
8. G.M. Eisen, R.S. Sandler, S. Murray, and M. Gottfried The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus Am J Gastroenterol 92 1997 27 31
9. D.V. Gopal, D.A. Lieberman, N. Magaret, M.B. Fennerty, R.E. Sampliner, and H.S. Garewal Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium Dig Dis Sci 48 2003 1537 1541
10. W.K. Hirota, T.M. Loughney, D.J. Lazas, C.L. Mayudonovitch, V. Rholl, and R.K. Wong Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data Gastroenterology 116 1999 277 285
11. A.P. Weston, A.S. Badr, and R.S. Hassanein Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma Am J Gastroenterol 94 1999 3413 3419
12. B. Avidan, A. Sonnenberg, T.G. Schnell, and S.J. Sontag Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus Dig Dis Sci 47 2002 256 264
13. T. Loughney, C.L. Maydonovitch, and R.K. Wong Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus Am J Gastroenterol 93 1998 916 919
14. R. Fass, R.W. Hell, H.S. Garewal, P. Martinez, G. Pulliam, and C. Wendel Correlation of oesophageal acid exposure with Barrett's oesophagus length Gut 748 2001 310 313
15. D.E. Wakelin, T. Al-Mutawa, C. Wendel, C. Green, H.S. Garewal, and R. Fass A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure Gastrointest Endosc 58 2003 350 355
16. E.F. Tharalson, S.D. Martinez, H.S. Garewal, R.E. Sampliner, H. Cui, and G. Pulliam Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium Am J Gastroenterol 97 2002 851 856
17. A. Csendes, G. Smok, J. Quiroz, P. Burdiles, J. Rojas, and C. Castro Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia Am J Gastroenterol 97 2002 554 560
18. S. Öberg, T.R. DeMeester, J.H. Peters, J.A. Hagen, J.J. Nigro, and S.R. DeMeester The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure J Thorac Cardiovasc Surg 117 1999 572 580
19. R. Fass Letter to the editor: acid exposure in Barrett's esophagus Gut 52 2003 153 154
20. G.R. Locke, N.J. Talley, A.L. Weaver, and A.R. Zinsmeister A new questionnaire for gastroesophageal reflux disease Mayo Clin Proc 69 1994 539 547
21. R.E. Sampliner Detecting, measuring, and managing Barrett's esophagus: the complete endoscopist's dilemma Gastrointest Endosc 45 1997 533 535
22. R.E. Sampliner Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 93 1998 1028 1032
23. H.B. El-Serag, T. Aguirre, M. Kuebeler, and R.E. Sampliner The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy Aliment Pharmacol Ther 19 2004 1255 1260
24. R. Fass, M.B. Fennerty, J.J. Ofman, I.M. Gralnek, C. Johnson, and E. Camargo The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain Gastroenterology 115 1998 42 49
25. G. Zaninotto, G. Portale, A. Parenti, C. Lanza, M. Costantini, and D. Molena Role of acid and bile reflux in development of specialised intestinal metaplasia in distal oesophagus Dig Liver Dis 34 2002 251 257
26. M.F. Vaezi, and J.E. Richter Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease Gastroenterology 111 1996 1192 1199
27. R.E. Rudolph, T.L. Vaughan, B.E. Storer, R.C. Haggitt, P.S. Rabinovitch, and D.S. Levine Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus Ann Intern Med 132 2000 612 620
28. B. Avidan, A. Sonnenberg, T.G. Schnell, G. Chejfec, A. Metz, and S.J. Sontag Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma Am J Gastroenterol 97 2002 1930 1936
29. A.J. Cameron Barrett's esophagus: prevalence and size of hiatal hernia Am J Gastroenterol 94 1999 2054 2059
30. M.G. Patti, H.I. Goldberg, M. Arcertito, L. Bortolasi, J. Tong, and L.W. Way Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury Am J Surg 171 1996 182 186
31. S.J. Sontag, T.G. Schnell, T.G. Miller, B. Nemchausky, R. Serlovsky, and S. O'Connell The importance of hiatal hernia in reflux esophagitis compared with lower esophageal sphincter pressure or smoking J Clin Gastroenterol 13 1991 628 643
32. R.K. Mittal, R.C. Lange, and R.W. McCallum Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia Gastroenterology 92 1987 130 135
33. S. Sloan, and P.J. Kahrilas Impairment of esophageal emptying with hiatal hernia Gastroenterology 100 1991 596 605
34. P. Kasapidis, J.S. Vassilakis, G. Tzovaras, E. Chrysos, and E. Xynos Effect of hiatal hernia on esophageal manometry and pH-metry in gastroesophageal reflux disease Dig Dis Sci 40 1995 2724 2730
35. M. Frazzoni, E. De Micheli, A. Grisendi, and V. Savarino Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression Aliment Pharmacol Ther 16 2002 881 886
36. H.B. El-Serag, T.V. Aguirre, S. Davis, M. Kuebeler, A. Bhattacharyya, and R.E. Sampliner Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus Am J Gastroenterol 99 2004 1877 1883
37. J. Lagergren, R. Bergstrom, and O. Nyren Association between body mass and adenocarcinoma of the esophagus and gastric cardia Ann Intern Med 130 1999 883 890
38. T.L. Vaughan, A.R. Kristal, P.L. Blount, D.S. Levine, P.C. Galipeau, and L.J. Prevo Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 11 2002 745 752
39. R. Kim, J.L. Weissfeld, J.C. Reynolds, and L.H. Kuller Etiology of Barrett's metaplasia and esophageal adenocarcinoma Cancer Epidemiol Biomarkers Prev 6 1997 369 377